These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15168808)

  • 1. Immune sensitization to yeast antigens in ASCA-positive patients with Crohn's disease.
    Konrad A; Rütten C; Flogerzi B; Styner M; Göke B; Seibold F
    Inflamm Bowel Dis; 2004 Mar; 10(2):97-105. PubMed ID: 15168808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic variants of the mannan-binding lectin are associated with immune reactivity to mannans in Crohn's disease.
    Seibold F; Konrad A; Flogerzi B; Seibold-Schmid B; Arni S; Jüliger S; Kun JF
    Gastroenterology; 2004 Oct; 127(4):1076-84. PubMed ID: 15480986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Saccharomyces cerevisiae mannan antibodies (ASCA) of Crohn's patients crossreact with mannan from other yeast strains, and murine ASCA IgM can be experimentally induced with Candida albicans.
    Schaffer T; Müller S; Flogerzi B; Seibold-Schmid B; Schoepfer AM; Seibold F
    Inflamm Bowel Dis; 2007 Nov; 13(11):1339-46. PubMed ID: 17636567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Saccharomyces cerevisiae antibody titers are stable over time in Crohn's patients and are not inducible in murine models of colitis.
    Müller S; Styner M; Seibold-Schmid B; Flogerzi B; Mähler M; Konrad A; Seibold F
    World J Gastroenterol; 2005 Nov; 11(44):6988-94. PubMed ID: 16437604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low Mannan-binding lectin serum levels are associated with complicated Crohn's disease and reactivity to oligomannan (ASCA).
    Schoepfer AM; Flogerzi B; Seibold-Schmid B; Schaffer T; Kun JF; Pittet V; Mueller S; Seibold F
    Am J Gastroenterol; 2009 Oct; 104(10):2508-16. PubMed ID: 19532127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-Saccharomyces cerevisiae mannan antibodies and antineutrophil cytoplasmic autoantibodies in Greek patients with inflammatory bowel disease.
    Koutroubakis IE; Petinaki E; Mouzas IA; Vlachonikolis IG; Anagnostopoulou E; Castanas E; Maniatis AN; Kouroumalis EA
    Am J Gastroenterol; 2001 Feb; 96(2):449-54. PubMed ID: 11232689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of antisynthetic mannoside antibodies (ASigmaMA) reveals heterogeneity in the ASCA response of Crohn's disease patients and contributes to differential diagnosis, stratification, and prediction.
    Vandewalle-El Khoury P; Colombel JF; Joossens S; Standaert-Vitse A; Collot M; Halfvarson J; Ayadi A; Landers CJ; Vermeire S; Rutgeerts P; Targan SR; Chamaillard M; Mallet JM; Sendid B; Poulain D
    Am J Gastroenterol; 2008 Apr; 103(4):949-57. PubMed ID: 18047546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial overlap of anti-mycobacterial, and anti-Saccharomyces cerevisiae mannan antibodies in Crohn's disease.
    Müller S; Schaffer T; Schoepfer AM; Hilty A; Bodmer T; Seibold F
    World J Gastroenterol; 2008 Jun; 14(23):3650-61. PubMed ID: 18595132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Saccharomyces cerevisiae mannan antibodies in inflammatory bowel disease: comparison of different assays and correlation with clinical features.
    Annese V; Piepoli A; Perri F; Lombardi G; Latiano A; Napolitano G; Corritore G; Vandewalle P; Poulain D; Colombel JF; Andriulli A
    Aliment Pharmacol Ther; 2004 Nov; 20(10):1143-52. PubMed ID: 15569117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baker's yeast (Saccharomyces cerevisiae) antigen in obese and normal weight subjects.
    Salamati S; Martins C; Kulseng B
    Clin Obes; 2015 Feb; 5(1):42-7. PubMed ID: 25611585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Candida albicans is an immunogen for anti-Saccharomyces cerevisiae antibody markers of Crohn's disease.
    Standaert-Vitse A; Jouault T; Vandewalle P; Mille C; Seddik M; Sendid B; Mallet JM; Colombel JF; Poulain D
    Gastroenterology; 2006 May; 130(6):1764-75. PubMed ID: 16697740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased titers of anti-Saccharomyces cerevisiae antibodies in Crohn's disease patients with reduced H-ficolin levels but normal MASP-2 activity.
    Schaffer T; Flogerzi B; Schoepfer AM; Seibold F; Müller S
    J Crohns Colitis; 2013 Feb; 7(1):e1-10. PubMed ID: 22445443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-Saccharomyces cerevisiae mannan antibodies in familial Crohn's disease.
    Sendid B; Quinton JF; Charrier G; Goulet O; Cortot A; Grandbastien B; Poulain D; Colombel JF
    Am J Gastroenterol; 1998 Aug; 93(8):1306-10. PubMed ID: 9707056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role.
    Quinton JF; Sendid B; Reumaux D; Duthilleul P; Cortot A; Grandbastien B; Charrier G; Targan SR; Colombel JF; Poulain D
    Gut; 1998 Jun; 42(6):788-91. PubMed ID: 9691915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of deficiency for mannan-binding lectin with anti-mannan antibodies in Crohn's disease: a family study.
    Seibold F; Boldt AB; Seibold-Schmid B; Schoepfer AM; Flogerzi B; Müller S; Kun JF
    Inflamm Bowel Dis; 2007 Sep; 13(9):1077-82. PubMed ID: 17480019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto- and microbial antigens.
    Landers CJ; Cohavy O; Misra R; Yang H; Lin YC; Braun J; Targan SR
    Gastroenterology; 2002 Sep; 123(3):689-99. PubMed ID: 12198693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnostic role of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in pediatric inflammatory bowel disease].
    Kim JE; Kim KS; Seo JK
    Korean J Gastroenterol; 2003 Oct; 42(4):297-302. PubMed ID: 14634349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific antibody response to oligomannosidic epitopes in Crohn's disease.
    Sendid B; Colombel JF; Jacquinot PM; Faille C; Fruit J; Cortot A; Lucidarme D; Camus D; Poulain D
    Clin Diagn Lab Immunol; 1996 Mar; 3(2):219-26. PubMed ID: 8991640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Higher titers of anti-Saccharomyces cerevisiae antibodies IgA and IgG are associated with more aggressive phenotypes in Romanian patients with Crohn's disease.
    Gologan S; Iacob R; Preda C; Vadan R; Cotruta B; Catuneanu AM; Iacob S; Constantinescu I; Gheorghe L; Iobagiu S; Gheorghe C; Diculescu M
    J Gastrointestin Liver Dis; 2012 Mar; 21(1):39-44. PubMed ID: 22457858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimising the diagnostic value of anti-Saccharomyces cerevisiae-antibodies (ASCA) in Crohn's disease.
    Klebl FH; Bataille F; Hofstädter F; Herfarth H; Schölmerich J; Rogler G
    Int J Colorectal Dis; 2004 Jul; 19(4):319-24. PubMed ID: 14745572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.